Scroll for more

Enabling 21st Century scientific innovation

BenevolentAI is the world leader in the development and application of artificial intelligence for scientific innovation.  We are the largest private AI company in Europe and one of the top five private AI companies in the world.  

Changing the way discovery happens

Despite the explosive growth of data, scientific discovery has not changed for 50 years.  It is impossible for humans alone to process all the world’s available scientific data and literature.  Consequently, only a tiny fraction of scientific knowledge is accessible, decipherable and usable at any one point in time to a given scientist.

Augmenting human intelligence

BenevolentAI uses proprietary AI and machine learning technology, together with its own unique team of pioneering scientists, to look deeply into vast scientific research data sets - rapidly forming and qualifying hypotheses, generating new insights and enabling hitherto impossible scientific intuition and innovation at previously unimaginable scale.  

Discovering new medicines

We began with a focus on bioscience – increasing the understanding of human biology by ingesting the entire compendium of information on human health and biological systems.  We are applying this knowledge to pharmaceutical development to bring better medicines to patients faster.

Our benevolent world

Find out what’s been going on in our benevolent world below, from our latest news, events and breaking research developments.

Aug 8, 2017 news - announcements

BenevolentAI announces New York office opening and new hires

BenevolentAI, one of the world’s largest private AI companies, today announced it is expanding its footprint in the United States by opening an office in New York City and has made two significant hires - Keith Hall, from Google, and Daniel Neil, from the Institute of Neuroinformatics, that will form the foundation of the new New York BenevolentAI team.

View news
Jul 20, 2017 news - announcements

BenevolentAI hires new head of cheminformatics from the Institute of Cancer Research

One of the world’s largest private AI companies – BenevolentAI, that develops and applies artificial intelligence for scientific innovation, today announced it has hired Dr Nathan Brown BSc (Hons) FRSC, as its new Head of Cheminformatics following the promotion of Mark Davies from Head of Cheminformatics at BenevolentAI to VP Biomedical Informatics earlier in the year.

View news
May 25, 2017 news - announcements

AI enabled research shows delay in onset of motor neurone disease

Sheffield and London, UK - 25 May 2017.  The Sheffield Institute for Translational Neuroscience (SITraN), part of the University of Sheffield and one of the world’s leading centres for research into Motor Neurone Disease, Alzheimer’s and Parkinson’s Disease, today announced that its research into a drug candidate discovered by British artificial intelligence firm BenevolentAI has delivered positive results.

View news

We are hiring

It’s BenevolentAI's people that drive its innovation and fuel its ambition to create usable knowledge that benefits society. 

Join our team

Contact us


General enquiries

hello@benevolent.ai
+44 20 3096 0720

Press

press@benevolent.ai
+44 20 7025 6684

Careers

careers@benevolent.ai
+44 20 3096 0720

Offices


London

40 Churchway, London, NW1 1LW

 


New York

222 Broadway, New York, 10038